August 30, 2016 11:31 PM ET

Biotechnology

Company Overview of ACADIA Pharmaceuticals Inc.

Executive Profile

Stephen R. Davis J.D.

Chief Executive Officer, President and Director, ACADIA Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 7 different industries.

See Board Relationships
55$12,133,066
As of Fiscal Year 2015

Background

Mr. Stephen R. Davis, also known as Steve, J.D., has been the Chief Executive Officer and President of ACADIA Pharmaceuticals, Inc. since September 1, 2015 and served as its Chief Financial Officer from July 15, 2014 to September 6, 2015. Mr. Davis served as the Chief Business Officer and Executive Vice President of ACADIA Pharmaceuticals, Inc. from July 15, 2014 to September 1, 2015 and as its Interim Chief Executive Officer from March 2015 to September 1, 2015. Mr. ...

Corporate Headquarters

3611 Valley Centre Drive
San Diego, California 92130

United States

Phone: 858-558-2871
Fax: 858-558-2872

Board Members Memberships

2013-Present
Director, Chairman of Audit Committee and Member of Nominating & Governance Committee
2015-Present
Chief Executive Officer, President and Director
2015-Present
Director and Chairman of Audit Committee

Education

JD
Vanderbilt University
BS
Southern Nazarene University

Other Affiliations

Annual Compensation

Salary$507,452
Bonus$248,651
Total Annual Compensation$756,103

Stocks Options

All Other Compensation$100,770
Exercisable Options$113,333
Unexercisable Options$651,667
Total Number of Options$765,000

Total Compensation

Total Annual Cash Compensation$856,873
Total Short Term Compensation$756,103
Other Long Term Compensation$100,770
Total Calculated Compensation$12,133,066
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Cohen M.D.Founder, Chief Executive Officer, President and Director
Acorda Therapeutics, Inc.
$768.8K
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Ionis Pharmaceuticals, Inc.
$1.5M
James A. Schoeneck Chief Executive Officer, President and Director
Depomed, Inc.
$708.3K
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$1.0M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ACADIA Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.